Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota

Anurag K. Sinha,Martin F. Laursen,Julius E. Brinck,Morten L. Rybtke,Anna Pii Hjørne,Nicola Procházková,Mikael Pedersen,Henrik M. Roager,Tine R. Licht

DOI: https://doi.org/10.1038/s41564-024-01737-3

IF: 28.3

2024-06-26

Nature Microbiology

Abstract:Tryptophan is catabolized by gut microorganisms resulting in a wide range of metabolites implicated in both beneficial and adverse host effects. How gut microbial tryptophan metabolism is directed towards indole, associated with chronic kidney disease, or towards protective indolelactic acid (ILA) and indolepropionic acid (IPA) is unclear. Here we used in vitro culturing and animal experiments to assess gut microbial competition for tryptophan and the resulting metabolites in a controlled three-species defined community and in complex undefined human faecal communities. The generation of specific tryptophan-derived metabolites was not predominantly determined by the abundance of tryptophan-metabolizing bacteria, but rather by substrate-dependent regulation of specific metabolic pathways. Indole-producing Escherichia coli and ILA- and IPA-producing Clostridium sporogenes competed for tryptophan within the three-species community in vitro and in vivo. Importantly, fibre-degrading Bacteroides thetaiotaomicron affected this competition by cross-feeding monosaccharides to E. coli . This inhibited indole production through catabolite repression, thus making more tryptophan available to C. sporogenes , resulting in increased ILA and IPA production. The fibre-dependent reduction in indole was confirmed using human faecal cultures and faecal-microbiota-transplanted gnotobiotic mice. Our findings explain why consumption of fermentable fibres suppresses indole production but promotes the generation of other tryptophan metabolites associated with health benefits.

microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand how dietary fiber affects host health by regulating tryptophan metabolism in the gut microbiota. Specifically, the study aims to explore how tryptophan is competitively utilized by different bacterial species in the gut microbiota and ultimately generates beneficial or harmful metabolites. The paper focuses on two metabolic pathways: the production of indole (associated with chronic kidney disease) via the tryptophanase pathway, and the production of the protective indole - 3 - lactate (ILA) and indole - 3 - propionic acid (IPA) via the Stickland fermentation pathway. The study evaluated the competitive utilization of tryptophan and its resulting metabolites in a controlled three - species - defined community and a complex human fecal community through in vitro culture and animal experiments.

The study found that the production of specific tryptophan - derived metabolites is not mainly determined by the abundance of tryptophan - metabolizing bacteria, but by specific substrate - dependent regulatory metabolic pathways. In particular, the study found that fiber - degrading species such as **Bacteroides thetaiotaomicron** inhibit indole production by providing monosaccharides to **Escherichia coli**, thereby making more tryptophan available for **Clostridium sporogenes** to carry out Stickland fermentation and increasing the production of ILA and IPA. This process was verified in human fecal cultures and fecal microbiota transplantation experiments in germ - free mice.

In conclusion, this study reveals how dietary fiber can have a positive impact on host health by changing the metabolic interactions in the gut microbiota, reducing the production of the harmful metabolite indole while promoting the production of the beneficial metabolites ILA and IPA.